Small-Molecule Parkinson's Disease Kinase Inhibitor LRRK2-in-1 Demonstrates Potent Anti-Cancer Activity Through Inhibition of DCLK1

被引:0
作者
Weygant, Nathaniel
Qu, Dongfeng
Berry, William L.
May, Randal
Chandrakesan, Parthasarathy
Owen, Daniel
Ali, Naushad
Janknecht, Ralf
Sureban, Sripathi M.
Houchen, Courtney W.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1929
引用
收藏
页码:S694 / S694
页数:1
相关论文
共 48 条
[31]   OXA-01, novel potent mTORC1/TORC2 kinase inhibitor, demonstrates broad spectrum antitumor activity in preclinical models of human cancer [J].
Gokhale, P. C. ;
Bhagwat, S. V. ;
Crew, A. P. ;
Cooke, A. ;
Mantis, C. ;
Workman, J. E. ;
Landfair, D. ;
Bittner, M. ;
Pachter, J. A. ;
Wild, R. .
EJC SUPPLEMENTS, 2008, 6 (12) :82-82
[32]   Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2 [J].
Wang, Bo-Wei ;
Huang, Chih-Hao ;
Liu, Liang-Chih ;
Cheng, Fang-Ju ;
Wei, Ya-Ling ;
Lin, Yueh-Ming ;
Wang, Yu-Fei ;
Wei, Ching-Ting ;
Chen, Yeh ;
Chen, Yun-Ju ;
Huang, Wei-Chien .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[33]   Enhancing nab-paclitaxel antitumor activity through addition of BMS-754807, a small-molecule inhibitor of IGF1R/IR, in experimental pancreatic cancer [J].
Awasthi, Niranjan ;
Schwarz, Margaret A. ;
Schwarz, Roderich E. .
CANCER RESEARCH, 2015, 75
[34]   Protective Effect of the LRRK2 Kinase Inhibition in Human Fibroblasts Bearing the Genetic Variant GBA1 K198E: Implications for Parkinson's Disease [J].
Perez-Abshana, Laura Patricia ;
Mendivil-Perez, Miguel ;
Velez-Pardo, Carlos ;
Jimenez-Del-Rio, Marlene .
NEUROMOLECULAR MEDICINE, 2025, 27 (01)
[35]   Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1 [J].
Zhu, Kai-Chang ;
Sun, Jian-Mei ;
Shen, Jian-Guo ;
Jin, Ji-Zhong ;
Liu, Feng ;
Xu, Xiao-Lin ;
Chen, Lin ;
Liu, Lin-Tao ;
Lv, Jia-Ju .
ONCOLOGY LETTERS, 2015, 10 (04) :2359-2365
[36]   ANTI-TUMOR ACTIVITY OF CB-668, A POTENT, SELECTIVE AND ORALLY BIOAVAILABLE SMALL-MOLECULE INHIBITOR OF THE IMMUNO-SUPPRESSIVE ENZYME INTERLEUKIN 4 (IL-4)-INDUCED GENE 1 (IL4I1) [J].
MacKinnon, Andrew ;
Bhupathi, Deepthi ;
Chen, Jason ;
Huang, Tony ;
Li, Weiqun ;
Ma, Yong ;
Sotirovska, Natalija ;
Steggerda, Susanne ;
Zhang, Winter ;
Parlati, Francesco .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 :A423-A424
[37]   Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APEI repair and redox activity in non-small-cell lung cancer [J].
Ren, Tao ;
Shan, Jinlu ;
Li, Mengxia ;
Qing, Yi ;
Qian, Chengyuan ;
Wang, Guangjie ;
Li, Qing ;
Lu, Guoshou ;
Li, Chongyi ;
Peng, Yu ;
Luo, Hao ;
Zhang, Shiheng ;
Yang, Yuxing ;
Cheng, Yi ;
Wang, Dong ;
Zhou, Shu-Feng .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :2887-2910
[38]   Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity [J].
Dorr, P ;
Westby, M ;
Dobbs, S ;
Griffin, P ;
Irvine, B ;
Macartney, M ;
Mori, J ;
Rickett, G ;
Smith-Burchnell, C ;
Napier, C ;
Webster, R ;
Armour, D ;
Price, D ;
Stammen, B ;
Wood, A ;
Perros, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4721-4732
[39]   Probing hGFAT1 activity through small-molecule inhibition, CRISPR and Cryo-EM: Identifying the downstream effects of O-GlcNAc modified proteins and their role in cancer cell survival [J].
Walter, Lisa ;
Lin, Yu Hsuan ;
Chuh, Kelly ;
Nasertorabi, Fariborz ;
Stevens, Raymond ;
Pratt, Matthew .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[40]   Identification of a Novel Selective Small-Molecule Inhibitor of the BMP Type I Receptor Kinase ACVR1/ALK2 with Disease-Modifying Potential for On-Target Therapy of Fibrodysplasia Ossificans Progressiva (FOP) [J].
Kramer, Ina ;
Arista, Luca ;
Head, Victoria ;
Kneissel, Michaela ;
Ullrich, Thomas ;
Guth-Gundel, Sabine .
JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 :58-59